Location History:
- Köln, DE (2005 - 2019)
- Cologne, DE (2022)
Company Filing History:
2 out of 54 
1 out of 721 
1 out of 12,160 
Years Active: 2005-2022
Title: Inventor Spotlight: Wolfgang Wiehl from Köln, DE
Introduction:
Meet Wolfgang Wiehl, an innovative inventor hailing from Köln, DE, who has made significant contributions in the field of animal health and pharmaceutical compositions. With a total of 4 patents under his name, Wolfgang Wiehl's expertise shines through in his groundbreaking inventions aimed at controlling and preventing animal parasites and treating mastitis in non-human mammals.
Latest Patents:
1. Topically administrable formulation for the control and prevention of animal parasites: Wolfgang Wiehl's latest invention introduces novel liquid formulations designed for the topical administration to animals. These formulations consist of a fluorine-containing antiparasitic active compound and triethyl phosphate, proving effective in the control and prevention of animal parasites.
2. Pharmaceutical compositions and treatment of mastitis: Another notable patent by Wolfgang Wiehl focuses on pharmaceutical compositions and methods for addressing mastitis in non-human mammals, specifically in cows. The composition comprises a blend of phosphonic acid and antimicrobial compounds, offering a promising approach to managing this common health concern in livestock.
Career Highlights:
Throughout his career, Wolfgang Wiehl has made invaluable contributions while working at Bayer Animal Health GmbH and Bayer Intellectual Property GmbH. His exceptional work ethic and dedication to innovation have not only resulted in impactful inventions but also solidified his reputation as a visionary in the field.
Collaborations:
Wolfgang Wiehl has had the privilege of collaborating with esteemed professionals in the industry, including Petra Ohage-Spitzlei and Franziska Schmidt. Together, they have shared their expertise and insights, further enhancing the impact of their collective work in advancing animal health and pharmaceutical research.
Conclusion:
In conclusion, Wolfgang Wiehl's passion for innovation and commitment to advancing animal health and pharmaceutical research are evident in his impressive portfolio of patents. His inventive spirit, combined with his collaborative efforts with industry experts, continues to drive progress in addressing critical health issues in non-human mammals. Wolfgang Wiehl stands as a testament to the power of ingenuity and dedication in transforming the landscape of animal healthcare.